When Jannsen walked it left the door open to other partners too so the return of Jannsen or the entrant of a new partner that gets to start where they left off may not be too far away. Maybe some of the work being done with Genentech is follow on?
still think if they can deliver a couple of positives between now and the end if the year there is no reason why it can be valued in the 50-100m range.
- Forums
- ASX - By Stock
- timeline to a decision
PYC
pyc therapeutics limited
Add to My Watchlist
0.00%
!
$1.32

When Jannsen walked it left the door open to other partners too...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.32 |
Change
0.000(0.00%) |
Mkt cap ! $769.9M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.31 | $552.6K | 416.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2187 | $1.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.33 | 14814 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2174 | 1.315 |
8 | 18638 | 1.310 |
3 | 23736 | 1.305 |
5 | 97061 | 1.300 |
1 | 1186 | 1.290 |
Price($) | Vol. | No. |
---|---|---|
1.330 | 14814 | 3 |
1.335 | 22415 | 1 |
1.340 | 5130 | 2 |
1.345 | 42769 | 1 |
1.350 | 23186 | 3 |
Last trade - 11.41am 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online